Using Infrared Spectroscopy for Diagnosis Severity of Nonalcoholic Fatty Liver Disease
NCT02860884 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 136
Last updated 2016-08-09
Summary
The main objective of this study is to evaluate the ability of infrared spectroscopy to discriminate simple hepatic steatosis from NASH
Conditions
- Fatty Liver
- Non-alcoholic Fatty Liver Disease
Interventions
- PROCEDURE
-
liver biopsy
- OTHER
-
infrared spectroscopy
Sponsors & Collaborators
-
Rennes University Hospital
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-08-31
- Primary Completion
- 2015-04-30
- Completion
- 2015-10-31
Countries
- France
Study Locations
More Related Trials
-
Non Invasive Measurements of Fibrosis, Inflammation and Steatohepatitis in Morbidly Obese Patients
NCT01695083 ·Status: COMPLETED
-
Study of Liver Fibrosis Stage Assessment by Fibroblast Activation Protein Imaging in Patients With Biopsy for Suspected or Proven Nonalcoholic Steatohepatitis
NCT06160271 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Signature Diagnostic of Non-alcoholic Steatohepatitis (NASH) by Infrared Light Spectroscopy
NCT03978247 ·Status: COMPLETED ·Phase: NA
-
Hepatic Fibrosis Assessment Using Multiparametric Magnetic Resonance Imaging
NCT02480972 ·Status: COMPLETED ·Phase: NA
-
Comparison of Biannual Ultrasonography and Annual Unenhanced Magnetic Resonance Imaging for HCC Surveillance
NCT02854241 ·Status: UNKNOWN ·Phase: NA
-
Evaluation of 4 MRI Methods (PDFF 3, 6 and 11 Gradient Echoes and Spectroscopy) Compared to the Reference Method (Liver Biopsy) in Quantification of Hepatic Steatosis
NCT03142698 ·Status: UNKNOWN ·Phase: NA
-
Exploratory Study of MRI Biomarkers of NASH
NCT06626074 ·Status: RECRUITING ·Phase: NA
-
Non-invasive Evaluation of Liver Fibrosis, Steatosis, and NASH in NAFLD
NCT03725631 ·Status: UNKNOWN ·Phase: NA
-
Non-invasive Diagnosis of Non-alcoholic Steatohepatitis in Liver Transplant Recipients
NCT03128918 ·Status: UNKNOWN
-
Quantification of Hepatic Steatosis With Different Ultrasound Frequency
NCT05855239 ·Status: ACTIVE_NOT_RECRUITING
-
Ga-68 Dolacga PET Scan in HCC Under RFA
NCT06792097 ·Status: NOT_YET_RECRUITING
-
Non-invasive Diagnostic Model of Liver Fibrosis Associated With NAFLD and Prediction of Prognosis
NCT03842748 ·Status: UNKNOWN
-
Usefulness of Multi-parametric, Quantitative MR Imaging for Staging of Hepatic Fibrosis in the Patients With Chronic Hepatitis
NCT01981421 ·Status: UNKNOWN
-
Quantitative Ultrasound Techniques for Diagnosis of Nonalcoholic Steatohepatitis
NCT03572465 ·Status: RECRUITING
-
Prevalence of Non-Alcoholic Fatty Liver Disease in Inflammatory Bowel Disease Patients
NCT06814600 ·Status: RECRUITING
-
Assessment of Indocyanine Green as a Near-Infrared Fluorescent Contrast Agent for Image-guided Liver Surgery
NCT01738217 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Point-of-care Ultrasound Screening and Assessment of Chronic Liver Diseases and NASH
NCT05120557 ·Status: UNKNOWN ·Phase: NA
-
Screening of Liver Fibrosis Using Blood Tests in Patients With Type 2 Diabetes Mellitus
NCT04232293 ·Status: COMPLETED ·Phase: NA
-
Liver Fibrosis and Steatosis in dm Non Invasive Evaluation
NCT05605717 ·Status: UNKNOWN
-
Quantitative Diagnosis of Fatty Liver by Dual Energy CT Technique
NCT00172705 ·Status: UNKNOWN
-
The Relationship Between Fatty Liver and Breast Cancer
NCT06402084 ·Status: RECRUITING
-
Utilizing Non-Invasive Fibroscan® Technology to Identify Genetic Markers for Fatty Liver Progression
NCT02267148 ·Status: COMPLETED
-
Transient Elastography in the Determination of Advanced Fibrosis in Alcoholic Liver Disease.
NCT01789008 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Hepatic Function Using Gadoxetic Acid Enhanced MRI
NCT02854371 ·Status: COMPLETED ·Phase: PHASE4
-
Identification of Protective and Worsening Steatohepatitis (NASH) Factors
NCT00914446 ·Status: UNKNOWN ·Phase: NA